[This is about a drug to lower cholesterol in those who don’t tolerate statins]
“Still, evolocumab is likely to be controversial for some time, primarily because of its cost: $14,000 a year in the US. Last year, the National Institute for Health and Care Excellence in Britain recommended that doctors should not use Repatha, but the NHS says it is likely to revise its recommendation this year. Without Nice support, the NHS will not provide the drug”. FT
So, treat 4 people and you have spent a similar about to a junior medic, nurse or therapist?